Clinical Study

Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database

Table 5

Relative risks of all-cause mortality (excluding suicide) and cardiovascular outcomes for current users of various types of antipsychotics versus nonuser psychiatric controls stratified by dose.

OutcomeExposure type of current usersDoseOutcome eventsPerson-time (Years)Incidence rate per 1000 PY
(95% CI)
Fully adjusted RR (aRR)
(95% CI)

All-cause mortalityNonuser psychiatricNA7765307,27625.3 (24.7–25.8)Reference
Atypical or typicalLow21,208218,63597.0 (95.7–98.3)1.72 (1.62–1.84)
Medium197837,70452.5 (50.2–54.8)1.94 (1.80–2.10)
High65520,55331.9 (29.5–34.4)1.89 (1.71–2.09)
Atypical Low596951,838115.2 (112.3–118.1)1.51 (1.40–1.64)
Medium110628,87438.3 (36.1–40.6)1.54 (1.40–1.69)
High28113,40121.0 (18.6–23.6)1.48 (1.29–1.71)
Typical Low14,528160,26490.7 (89.2–92.1)1.76 (1.63–1.89)
Medium6834232161.4 (149.5–174.0)3.74 (3.36–4.15)
High2622509104.4 (92.2–117.9)3.61 (3.14–4.16)
OlanzapineLow87317,17250.8 (47.5–54.3)1.00 (0.88–1.13)
Medium32312,30426.3 (23.5–29.3)1.07 (0.92–1.24)
High109550919.8 (16.3–23.9)1.20 (0.97–1.49)*

Cardiac MortalityNonuser psychiatricNA1289200,9886.4 (6.1–6.8)Reference
Atypical or typicalLow2157107,87420.0 (19.2–20.9)1.65 (1.36–2.00)
Medium25125,2999.9 (8.7–11.2)2.10 (1.68–2.63)
High7012,4705.6 (4.4–7.1)2.27 (1.68–3.07)
Atypical Low98442,82423.0 (21.6–24.5)1.35 (1.24–1.47)
Medium17321,2588.1 (7.0–9.5)1.67 (1.42–1.97)
High4392024.7 (3.4–6.3)1.84 (1.35–2.51)
Typical Low110861,99917.9 (16.8–19.0)1.82 (1.44–2.32)
Medium571862 30.6 (23.2–39.7)3.40 (2.39–4.83)
High15105314.3 (8.0–23.5)3.13 (1.79–5.47)
OlanzapineLow12913,8979.3 (7.8–11.0)1.31 (0.93–1.82)
Medium6088516.8 (5.2–8.7)2.06 (1.41–3.01)
High1740164.2 (2.5–6.8)2.37 (1.36–4.12)

SCD (secondary definition)Nonuser psychiatricNA9823,8734.1 (3.3–5.0)Reference
Atypical or typicalLow15711,91413.2 (11.2–15.4)2.09 (1.60–2.75)
Medium1429564.7 (2.6–8.0)2.42 (1.35–4.35)
High712745.5 (2.2–11.3)3.36 (1.50–7.50)
Atypical Low82646912.7 (10.1-15.7)1.78 (1.31–2.42)
Medium626602.3 (0.8–4.9)1.32 (0.57–3.05)
High210721.9 (0.2–6.7)1.53 (0.37–6.39)
Typical Low70520213.5 (10.5–17.0)2.48 (1.81–3.40)
Medium515632.1 (10.4–74.8)6.07 (2.45–14.99)
High35752.8 (10.9–154.3)10.05 (3.15–32.08)
OlanzapineLow819514.1 (1.8–8.1)0 (NC)
Medium210521.9 (0.2–6.9)0 (NC)
High04510.0 (0.0-8.2)0 (NC)

CHDNonuser psychiatricNA982278,3303.5 (3.3–3.8)Reference
Atypical or typicalLow1192185,0326.4 (6.1–6.8)1.19 (0.96–1.48)
Medium12633,4403.8 (3.1–4.5)1.15 (0.88–1.50)
High3717,7572.1 (1.5 –2.9)0.86 (0.59–1.26)
Atypical Low32848,2236.8 (6.1–7.6)0.94 (0.72–1.23)
Medium9526,0593.7 (3.0–4.5)1.11 (0.81–1.51)
High2111,8331.8 (1.1–2.7)0.77 (0.47–1.26)
Typical Low843131,3636.4 (6.0–6.9)1.40 (1.10–1.78)
Medium2034135.9 (3.6–9.1)1.25 (0.76–2.05)
High1020015.0 (2.4–9.2)1.54 (0.80–2.98)
OlanzapineLow7615,8564.8 (3.8–6.0)0.99 (0.68–1.45)
Medium4611,0294.2 (3.1–5.6)1.34 (0.89–2.01)
High1049212.0 (1.0–3.7)0.82 (0.42–1.63)

Ventricular arrhythmiasNonuser psychiatricNA500279,2431.8 (1.6–2.0)Reference
Atypical or typicalLow540186,4172.9 (2.7–3.2)1.13 (0.99–1.29)*
Medium7033,4452.1 (1.6–2.6)1.27 (0.98–1.64)*
High3617,7842.0 (1.4–2.8)1.55 (1.08–2.20)
Atypical Low16348,3983.4 (2.9–3.9)1.03 (0.85–1.24)
Medium4826,0791.8 (1.4–2.4)1.12 (0.83–1.51)
High1911,8421.6 (1.0–2.5)1.27 (0.79–2.02)
Typical Low359132,5502.7 (2.4–3.0)1.13 (0.98–1.31)*
Medium1634164.7 (2.7–7.6)2.23 (1.35–3.69)
High720173.5 (1.4–7.2)2.11 (0.99–4.47)*
OlanzapineLow3315,9262.1 (1.4–2.9)0.84 (0.59–1.20)
Medium1411,0681.3 (0.7–2.1)0.78 (0.46–1.33)
High849271.6 (0.7–3.2)1.22 (0.60–2.46)

, , .
Abbreviations: aRR: adjusted relative risk; CHD: coronary heart disease; CI: confidence interval; NC: not calculable; PY: person-years; SCD: sudden cardiac death.